Consolidated Statements of Operations and Comprehensive Loss - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Operating expenses:
Research and development	$ 14,400	$ 8,132	$ 25,389	$ 17,410
General and administrative	6,639	4,299	11,771	8,036
Total operating expenses	21,039	12,431	37,160	25,446
Loss from operations	(21,039)	(12,431)	(37,160)	(25,446)
Other income:
Other income	1,508	119	2,522	98
Net loss	(19,531)	(12,312)	(34,638)	(25,348)
Unrealized (loss) gain on short-term investments	(43)	104	12	134
Comprehensive loss	$ (19,574)	$ (12,208)	$ (34,626)	$ (25,214)
Net loss per share attributable to common stockholders, basic	$ (0.65)	$ (0.5)	$ (1.25)	$ (1.04)
Net loss per share attributable to common stockholders, diluted	$ (0.65)	$ (0.5)	$ (1.25)	$ (1.04)
Weighted-average shares used in computing net loss per share, basic	30,215,321	24,463,824	27,640,172	24,461,085
Weighted-average shares used in computing net loss per share, diluted	30,215,321	24,463,824	27,640,172	24,461,085